Form 8-K - Current report:
SEC Accession No. 0001493152-24-035166
Filing Date
2024-09-05
Accepted
2024-09-05 16:45:12
Documents
20
Period of Report
2024-09-04
Items
Item 1.01: Entry into a Material Definitive Agreement
Item 8.01: Other Events
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 form8-k.htm   iXBRL 8-K 59086
2 ex1-1.htm EX-1.1 221162
3 ex4-1.htm EX-4.1 130016
4 ex4-2.htm EX-4.2 128062
5 ex4-3.htm EX-4.3 123290
6 ex10-1.htm EX-10.1 295326
7 ex99-1.htm EX-99.1 13040
8 ex99-2.htm EX-99.2 10042
  Complete submission text file 0001493152-24-035166.txt   1351287

Data Files

Seq Description Document Type Size
9 XBRL SCHEMA FILE ogen-20240904.xsd EX-101.SCH 3018
10 XBRL LABEL FILE ogen-20240904_lab.xml EX-101.LAB 34240
11 XBRL PRESENTATION FILE ogen-20240904_pre.xml EX-101.PRE 24167
22 EXTRACTED XBRL INSTANCE DOCUMENT form8-k_htm.xml XML 3659
Mailing Address 1990 MAIN STREET SUITE 750 SARASOTA FL 34236
Business Address 1990 MAIN STREET SUITE 750 SARASOTA FL 34236 8132867900
ORAGENICS INC (Filer) CIK: 0001174940 (see all company filings)

EIN.: 593410522 | State of Incorp.: FL | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-32188 | Film No.: 241281931
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)